Retinoic Acid Synthesis Deficiency Fosters the Generation of Polymorphonuclear Myeloid-Derived Suppressor Cells in Colorectal Cancer

Hong-Wei Sun,Jing Chen,Wen-Chao Wu,Yan-Yan Yang,Yi-Tuo Xu,Xing-Juan Yu,Hai-Tian Chen,Zilian Wang,Xiao-Jun Wu,Limin Zheng
DOI: https://doi.org/10.1158/2326-6066.cir-20-0389
IF: 10.1
2020-11-11
Cancer Immunology Research
Abstract:Metabolism is reprogrammed in cancer to fulfill the demands of malignant cells for cancer initiation and progression. Apart from its effects within cancer cells, little is known about whether and how reprogramed metabolism regulates the surrounding tumor microenvironment (TME). Myeloid-derived suppressor cells (MDSC) are key regulators of the TME and greatly affect tumor progression and therapeutic responses. In this study, our results revealed that retinol metabolism-related genes and enzymes were significantly downregulated in human colorectal cancer compared with adjacent colonic tissues, and tumors exhibited a defect in retinoic acid (RA) synthesis. Reduced ADH1-mediated retinol metabolism was associated with attenuated RA signaling and accumulated MDSCs in colorectal cancer tumors. Using an <i>in vitro</i> model, generating MDSCs from CD34<sup>+</sup> myeloid precursors, we found that exogenous RA could abrogate the generation of polymorphonuclear MDSCs (PMN-MDSC) with negligible impact on myeloid differentiation. Mechanistically, RA could restrain the glycolytic capacity of myeloid cells, which in turn activated the AMP-activated protein kinase (AMPK) pathway, further impairing the suppressive capacity of myeloid cells. Supplementation with RA could significantly delay tumor growth, with reduced arginase-1-expressing myeloid cells and increased CD8<sup>+</sup> and granzyme B<sup>+</sup> T cells in both colitis-associated and implanted MC38 mouse colorectal cancer models. Our results indicated that the defect in ADH1-mediated RA synthesis could provide a possible mechanism that fosters the generation of PMN-MDSCs in colorectal cancer and that restoring RA signaling in the TME could serve as a promising therapeutic strategy to abrogate the generation of PMN-MDSCs.
oncology,immunology
What problem does this paper attempt to address?
This paper aims to explore how the defect in retinoic acid (RA) synthesis promotes the generation of polymorphonuclear myeloid - derived suppressor cells (PMN - MDSCs) in colorectal cancer (CRC). Specifically, the study found that genes and enzymes related to retinol metabolism in CRC tumor tissues were significantly down - regulated, leading to a decrease in RA synthesis. This reduction in RA synthesis is related to the weakened RA signal in the tumor microenvironment and the accumulation of PMN - MDSCs. Through in vitro experiments, researchers found that exogenous RA can inhibit the generation of PMN - MDSCs without affecting the differentiation of myeloid cells. Mechanistically, RA activates the AMPK pathway by inhibiting the glycolytic capacity of myeloid cells, further weakening the inhibitory function of myeloid cells. In addition, RA supplementation significantly delayed tumor growth in a mouse CRC model, reduced the number of myeloid cells expressing arginase 1 (ARG1), and increased the number of CD8+ and granzyme B+ T cells. These results suggest that restoring the RA signal level in the tumor microenvironment may be an effective treatment strategy for inhibiting the generation of PMN - MDSCs. ### Main problems - **Research background**: Metabolic reprogramming is an important feature of cancer, which not only affects the proliferation and progression of cancer cells but may also regulate the tumor microenvironment (TME). MDSCs are key regulators in the TME and have a significant impact on tumor progression and treatment response. - **Research objective**: To explore how the defect in retinoic acid synthesis promotes the generation of PMN - MDSCs in colorectal cancer and its mechanism. ### Key findings 1. **Enzymes related to retinol metabolism are significantly down - regulated in CRC**: - Microarray analysis showed that genes and enzymes related to retinol metabolism in CRC tumor tissues were significantly down - regulated compared with normal colon tissues, especially the expression of ADH1 was significantly decreased. - Immunohistochemistry and qRT - PCR verified this result. 2. **RA signal is weakened in CRC**: - The decreased expression of ADH1 was associated with the decreased expression of the RA signaling molecule RIG - I. - Immunofluorescence staining showed that the expression of RIG - I in myeloid cells in tumor tissues was significantly decreased. 3. **RA inhibits the generation of PMN - MDSCs**: - In vitro experiments showed that exogenous RA can inhibit the generation of PMN - MDSCs from CD34+ myeloid precursor cells without affecting the differentiation of myeloid cells. - Mechanistically, RA activates the AMPK pathway by inhibiting the glycolytic capacity of myeloid cells, thereby weakening the inhibitory function of myeloid cells. 4. **The effect of RA supplementation in mouse models**: - In mouse models of colitis - associated CRC and MC38 cell - implanted mice, RA supplementation significantly delayed tumor growth, reduced the number of myeloid cells expressing ARG1, and increased the number of CD8+ and granzyme B+ T cells. ### Conclusion This study reveals the mechanism by which the defect in retinoic acid synthesis promotes the generation of PMN - MDSCs in colorectal cancer and proposes that restoring the RA signal level may be an effective treatment strategy for inhibiting the generation of PMN - MDSCs, thereby improving the effect of tumor immunotherapy.